Welcome to our dedicated page for Medifast news (Ticker: MED), a resource for investors and traders seeking the latest updates and insights on Medifast stock.
Medifast, Inc. (NYSE: MED) generates a steady flow of news centered on its health and wellness programs, metabolic health strategy, and financial performance. As the company behind the OPTAVIA® lifestyle system and the Metabolic Synchronization™ framework, Medifast regularly issues updates that highlight how it is addressing obesity, lifestyle change, and the broader challenge of metabolic dysfunction.
Readers of this MED news page can expect coverage of quarterly and annual financial results, including trends in revenue, the number of independent active earning OPTAVIA coaches, and revenue per active earning coach. These releases often include commentary from leadership on business transformation, strategic priorities, and the company’s focus on metabolic health and long-term growth.
Medifast also publishes scientific and clinical news, such as research presented at conferences like ObesityWeek. These updates describe studies on topics including lean mass preservation on the Optimal Weight 5 & 1 Plan®, the long-term effects of anti-obesity medications, and links between sleep quality and metabolic outcomes. Such items illustrate how the company’s Scientific & Clinical Affairs team and Scientific Advisory Board contribute to evidence-based program development.
In addition, investors and observers will find corporate and strategic announcements, including the introduction of Metabolic Synchronization™, shifts in positioning from weight loss to metabolic health, and leadership or governance changes documented in press releases and related SEC filings. The company also highlights brand and educational initiatives, such as the “Health by Design” docuseries that explores cultural and environmental factors influencing metabolic health and longevity.
This news page is a central resource for following Medifast’s evolving approach to metabolic health, its OPTAVIA coach network, research milestones, and key corporate developments. For those tracking MED, it offers a consolidated view of how the company communicates its strategy, science, and financial trajectory over time.
Medifast, Inc (NYSE: MED) will announce its third-quarter financial results for the period ending September 30, 2021, on November 4, 2021, after the market closes. The conference call, featuring CEO Dan Chard and CFO Jim Maloney, will begin at 4:30 p.m. ET, accessible via their website or by phone. Medifast is recognized for its OPTAVIA® health and wellness community, which has influenced 2 million lives, offering scientifically developed products and support for healthy habits.
Medifast (NYSE: MED) hosted its third annual Healthy Habits For All Week from September 20-26, 2021, aimed at improving health education and access in underserved communities. The event included employee volunteers distributing back-to-school bags and Chromebooks to local students in Baltimore. Medifast collaborated with nonprofits like No Kid Hungry, raising over $900,000 to provide up to 9 million meals for children in need. CEO Dan Chard emphasized the initiative's alignment with the company's mission to promote wellness among future generations.
Medifast (NYSE: MED) released survey findings indicating that support is essential for individuals pursuing health and wellness goals. Notably, 66% of U.S. adults reported that support has aided their journeys, while 81% believe having experienced support increases the likelihood of success in developing healthy habits. The survey also identified key support types: informational (75%), emotional (70%), and affirmational (70%). The OPTAVIA program emphasizes the importance of Coach support, aligning with these insights to foster client success.
Medifast, Inc. (NYSE: MED) announced a quarterly cash dividend of $1.42 per share, payable on November 8, 2021, to shareholders of record by September 21, 2021. The company aims to maintain a quarterly dividend program, yet future declarations depend on the Board of Directors' discretion. Medifast has established itself as a leader in the health and wellness sector, supporting clients through its OPTAVIA® platform. Factors influencing future dividend declarations include operational performance and market conditions.
Medifast, Inc (NYSE: MED) announced that its Chairman and CEO, Dan Chard, along with CFO Jim Maloney, will present at the Jefferies Virtual Fitness & Wellness Summit on September 15, 2021, at 11:00 a.m. ET. This presentation will be broadcast live via the Investor Relations section of Medifast's website and archived until September 29, 2021. Medifast is recognized for its OPTAVIA® program, which promotes healthy living through scientifically developed products and community support, impacting over 2 million lives.
On August 11, 2021, Medifast (NYSE: MED) launched the OPTAVIA app, enhancing its digital services for Clients and Coaches. This app, which has already been downloaded nearly 150,000 times, offers features like Lean & Green recipes, order history, and account management. The initiative is part of Medifast's strategy to improve digital infrastructure, enabling Coaches to better support Clients. The app's development reflects a commitment to continuous improvement based on user feedback, with plans for further enhancements and the upcoming OPTAVIA Connect app aimed at boosting Coach productivity.
Medifast (NYSE: MED) reported strong Q2 results for 2021, with revenue surging 79.2% to $394.2 million, driven by a 62.2% increase in active OPTAVIA Coaches to 59,200. Net income rose 114.1% to $47 million, translating to earnings per share (EPS) of $3.96. The company achieved a gross profit increase of 84.4%, reaching $293.7 million. Despite a 77.0% rise in SG&A expenses, operating income improved significantly. For FY 2021, Medifast anticipates revenue between $1.425 billion and $1.525 billion, with EPS guidance of $12.70 to $14.17.
Medifast (NYSE: MED) successfully hosted its annual OPTAVIA Convention from July 29 to August 1, 2021, in a hybrid format, attracting over 15,000 registrants. The event featured Coach-led educational sessions, community engagement activities, and celebrations for independent Coaches and their clients. A philanthropic fundraising initiative raised over $100,000 to provide nutritious meals for children in need, contributing to a total of 8 million meals funded to date. CEO Dan Chard emphasized the importance of connection and support amidst the challenges brought by the pandemic.
Medifast, Inc. (NYSE: MED) announced it will disclose its financial results for Q2 2021 on August 4, 2021, after market close. The conference call for discussing these results will start at 4:30 p.m. ET on the same day. Participants will include Chairman and CEO Dan Chard, and CFO Jim Maloney. The call will be live-streamed on the company's Investor Relations page and available for playback afterward. Medifast is recognized for its health and wellness brand OPTAVIA® and has been ranked among FORTUNE's 100 Fastest-Growing Companies in 2020.
Summary not available.